Viewing Study NCT04981795


Ignite Creation Date: 2025-12-24 @ 1:50 PM
Ignite Modification Date: 2026-02-03 @ 2:02 AM
Study NCT ID: NCT04981795
Status: RECRUITING
Last Update Posted: 2024-12-10
First Post: 2021-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
Sponsor: Incyte Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DLBCL View
None Lymphoma View